Aceto's future global headquarters: Building purchased in Port Washington, New York

Aceto Corporation (Nasdaq:ACET), a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.

The building, located at 4 Tri Harbor Court in Port Washington, New York, is a two story office/industrial building with approximately 50,000 square feet of space. It is anticipated that Aceto will move its corporate offices into the new building no later than April 2011, when the lease at its current location in Lake Success expires.

Commenting on the announcement, Vince Miata, President and CEO of Aceto, said, "We are excited with the purchase of a building that will become the future, global headquarters for Aceto Corporation. From a financial perspective, purchasing a building, as opposed to leasing space, we expect will allow us to lower our SG&A expenses and gives us an asset that could potentially appreciate over time. The purchase of the building also provides us with a platform from which we can continue to grow Aceto for the foreseeable future. In addition, we believe that owning this building will create a more positive image for Aceto amongst our employees, business partners and shareholders." 

SOURCE Aceto Corporation

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New lab method accelerates diagnosis of genetic disorders of the immune system